CBP loss of function was reported to play a critical role in the pathogenesis of several neurodegenerative conditions including polyglutamine diseases [31], [32], spinocerebellar ataxia type 7 [33], and spinal and bulbar muscular atrophy [34]. The gene discussed is CREBBP; the disease is spinocerebellar ataxia 7.